These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 10614617)

  • 1. Vitamin D and prostate cancer.
    Feldman D; Zhao XY; Krishnan AV
    Endocrinology; 2000 Jan; 141(1):5-9. PubMed ID: 10614617
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitamin D may reduce prostate cancer metastasis by several mechanisms including blocking Stat3.
    Grant WB
    Am J Pathol; 2008 Nov; 173(5):1589-90. PubMed ID: 18948436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human prostate cancer cells: inhibition of proliferation by vitamin D analogs.
    Schwartz GG; Oeler TA; Uskoković MR; Bahnson RR
    Anticancer Res; 1994; 14(3A):1077-81. PubMed ID: 8074453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells.
    Schwartz GG; Wang MH; Zang M; Singh RK; Siegal GP
    Cancer Epidemiol Biomarkers Prev; 1997 Sep; 6(9):727-32. PubMed ID: 9298581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 and prostate cancer cell proliferation in vivo.
    Schwartz GG; Hill CC; Oeler TA; Becich MJ; Bahnson RR
    Urology; 1995 Sep; 46(3):365-9. PubMed ID: 7660511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibition of cancer cells by an active metabolite of a novel vitamin D prodrug.
    Wang YR; Wigington DP; Strugnell SA; Knutson JC
    Anticancer Res; 2005; 25(6B):4333-9. PubMed ID: 16309237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vitamin D and cancer].
    Yamana K; Saito H; Takenouchi K; Azuma Y; Ishizuka S
    Clin Calcium; 2006 Jul; 16(7):1147-53. PubMed ID: 16816475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D-induced up-regulation of tumour necrosis factor alpha (TNF-alpha) in prostate cancer cells.
    Golovko O; Nazarova N; Tuohimaa P
    Life Sci; 2005 Jun; 77(5):562-77. PubMed ID: 15904673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
    Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS
    Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaches to optimizing vitamin D therapy in prostate cancer.
    Schwartz GG
    J Urol; 2011 Apr; 185(4):1179-80. PubMed ID: 21334691
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-genomic effects of the androgen receptor and vitamin D agonist are involved in suppressing invasive phenotype of prostate cancer cells.
    Bonaccorsi L; Marchiani S; Ferruzzi P; Muratori M; Crescioli C; Forti G; Maggi M; Baldi E
    Steroids; 2006 Apr; 71(4):304-9. PubMed ID: 16289173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordant Health Implications and Molecular Mechanisms of Vitamin D in Clinical and Preclinical Studies of Prostate Cancer: A Critical Appraisal of the Literature Data.
    Fendler A; Stephan C; Ralla B; Jung K
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D in the prevention and treatment of prostate cancer.
    Konety BR; Johnson CS; Trump DL; Getzenberg RH
    Semin Urol Oncol; 1999 May; 17(2):77-84. PubMed ID: 10332920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tardive response or miracle].
    Brun C
    Ugeskr Laeger; 2012 Nov; 174(45):2809. PubMed ID: 23304707
    [No Abstract]   [Full Text] [Related]  

  • 15. Vitamin D and its analogues and the prevention and treatment of osteoporosis.
    Davey DA
    S Afr Med J; 1997 Apr; 87(4):423-5. PubMed ID: 9254783
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug developers explore vitamin D benefits without the vitamin.
    Willyard C
    Nat Med; 2011 Jan; 17(1):9. PubMed ID: 21217659
    [No Abstract]   [Full Text] [Related]  

  • 17. Quality of life and pain relief during treatment with calcitriol and docetaxel in symptomatic metastatic androgen-independent prostate carcinoma.
    Beer TM; Eilers KM; Garzotto M; Hsieh YC; Mori M
    Cancer; 2004 Feb; 100(4):758-63. PubMed ID: 14770432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D analogues in insulin-dependent diabetes mellitus and other autoimmune diseases: a therapeutic perspective.
    Mauricio D; Mandrup-Poulsen T; Nerup J
    Diabetes Metab Rev; 1996 Apr; 12(1):57-68. PubMed ID: 8861501
    [No Abstract]   [Full Text] [Related]  

  • 19. Potentiation of the growth-inhibitory effects of vitamin D in prostate cancer by genistein.
    Krishnan AV; Swami S; Moreno J; Bhattacharyya RB; Peehl DM; Feldman D
    Nutr Rev; 2007 Aug; 65(8 Pt 2):S121-3. PubMed ID: 17867387
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular mechanisms mediating the anti-proliferative effects of Vitamin D in prostate cancer.
    Moreno J; Krishnan AV; Feldman D
    J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):31-6. PubMed ID: 16024246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.